Authors:
Raderer, M
Osterreicher, C
Machold, K
Formanek, M
Fiebiger, W
Penz, M
Dragosics, B
Chott, A
Citation: M. Raderer et al., Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease, ANN ONCOL, 12(7), 2001, pp. 937-939
Authors:
Fischbach, W
Dragosics, B
Kolve-Goebeler, ME
Ohmann, C
Greiner, A
Yang, Q
Bohm, S
Verreet, P
Horstmann, O
Busch, M
Duhmke, E
Muller-Hermelink, HK
Wilms, K
Citation: W. Fischbach et al., Primary gastric B-cell lymphoma: results of a prospective multicenter study (vol 119, pg 1191, 2000), GASTROENTY, 119(6), 2000, pp. 1809-1809
Authors:
Fischbach, W
Dragosics, B
Kolve-Goebeler, ME
Ohmann, C
Greiner, A
Yang, Q
Bohm, S
Verreet, P
Horstmann, O
Busch, M
Duhmke, E
Muller-Hermelink, HK
Wilms, K
Citation: W. Fischbach et al., Primary gastric B-cell lymphoma: Results of a prospective multicenter study, GASTROENTY, 119(5), 2000, pp. 1191-1202
Authors:
Raderer, M
Valencak, J
Osterreicher, C
Drach, J
Hejna, M
Kornek, G
Scheithauer, W
Brodowicz, T
Chott, A
Dragosics, B
Citation: M. Raderer et al., Chemotherapy for the treatment of patients with primary high grade gastricB-cell lymphoma of modified Ann Arbor Stages IE and IIE, CANCER, 88(9), 2000, pp. 1979-1985
Authors:
Raderer, M
Vorbeck, F
Formanek, M
Osterreicher, C
Valencak, J
Penz, M
Kornek, G
Hamilton, G
Dragosics, B
Chott, A
Citation: M. Raderer et al., Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma, BR J CANC, 83(4), 2000, pp. 454-457
Authors:
Gschwantler, M
Dragosics, B
Schutze, K
Wurzer, H
Hirschl, AM
Pasching, E
Wimmer, M
Klimpfinger, M
Oberhuber, G
Brandstatter, G
Hentschel, E
Weiss, W
Citation: M. Gschwantler et al., Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori - a randomized, controlled trial, ALIM PHARM, 13(8), 1999, pp. 1063-1069